The authors emphasized the importance of investing in "substance use treatment, harm reduction, and structural drivers of overdose" as the pandemic continues.
There are no benefits to treating patients with hydroxychloroquine after they have already been exposed to COVID-19, according to a new study published in the New England Journal of Medicine.
Drug therapy is typically recommended for the initial treatment of patients with atrial fibrillation, but new research suggests there could be a more effective way.